Fluoxetine versus trazodone: efficacy and activating-sedating effects.

Beasley, C M; Dornseif, B E; Pultz, J A; Bosomworth, J C; Sayler, M E

Beasley, C M; Dornseif, B E; Pultz, J A; Bosomworth, J C; Sayler, M E.

Affiliation

Beasley CM; Division of Clinical Neurosciences, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind. 46285.

J Clin Psychiatry ; 52(7): 294-9, 1991 Jul.

Article in En | MEDLINE | ID: mdl-2071559

Subject(s)

Depressive Disorder/drug therapy; Fluoxetine/therapeutic use; Trazodone/therapeutic use; Adult; Akathisia, Drug-Induced; Ambulatory Care; Anxiety/chemically induced; Depressive Disorder/psychology; Dizziness/chemically induced; Double-Blind Method; Female; Fluoxetine/adverse effects; Humans; Male; Placebos; Psychiatric Status Rating Scales; Rhinitis/chemically induced; Sleep/drug effects; Sleep Initiation and Maintenance Disorders/chemically induced; Trazodone/adverse effects; Tremor/chemically induced

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Trazodone / Fluoxetine / Depressive Disorder Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Psychiatry Year: 1991 Type: Article

Search on Google

XML

PubMed Links